Acarix A/S
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauri… Read more
Acarix A/S (ACARIX) - Total Assets
Latest total assets as of December 2025: Skr48.33 Million SEK
Based on the latest financial reports, Acarix A/S (ACARIX) holds total assets worth Skr48.33 Million SEK as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Acarix A/S - Total Assets Trend (2014–2025)
This chart illustrates how Acarix A/S’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Acarix A/S - Asset Composition Analysis
Current Asset Composition (December 2025)
Acarix A/S's total assets of Skr48.33 Million consist of 85.8% current assets and 14.2% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 37.8% |
| Accounts Receivable | Skr16.75 Million | 34.7% |
| Inventory | Skr6.46 Million | 13.4% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr6.47 Million | 13.4% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how Acarix A/S's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Acarix A/S's current assets represent 85.8% of total assets in 2025, a decrease from 88.4% in 2014.
- Cash Position: Cash and equivalents constituted 37.8% of total assets in 2025, down from 47.6% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 13.0% of total assets, an increase from 11.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 34.7% of total assets.
Acarix A/S Competitors by Total Assets
Key competitors of Acarix A/S based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Acarix A/S - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Acarix A/S generates 0.15x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Acarix A/S is currently not profitable relative to its asset base.
Acarix A/S - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.08 | 13.94 | 6.45 |
| Quick Ratio | 3.45 | 12.54 | 6.08 |
| Cash Ratio | 1.80 | 11.57 | 0.00 |
| Working Capital | Skr31.32 Million | Skr 65.54 Million | Skr 52.16 Million |
Acarix A/S - Advanced Valuation Insights
This section examines the relationship between Acarix A/S's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.53 |
| Latest Market Cap to Assets Ratio | 0.60 |
| Asset Growth Rate (YoY) | -40.2% |
| Total Assets | Skr48.33 Million |
| Market Capitalization | $28.86 Million USD |
Valuation Analysis
Below Book Valuation: The market values Acarix A/S's assets below their book value (0.60 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Acarix A/S's assets decreased by 40.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Acarix A/S (2014–2025)
The table below shows the annual total assets of Acarix A/S from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr48.33 Million | -40.16% |
| 2024-12-31 | Skr80.76 Million | +28.43% |
| 2023-12-31 | Skr62.88 Million | -9.49% |
| 2022-12-31 | Skr69.48 Million | -41.42% |
| 2021-12-31 | Skr118.60 Million | +31.86% |
| 2020-12-31 | Skr89.95 Million | +8.39% |
| 2019-12-31 | Skr82.98 Million | -12.83% |
| 2018-12-31 | Skr95.20 Million | -28.99% |
| 2017-12-31 | Skr134.06 Million | -22.64% |
| 2016-12-31 | Skr173.29 Million | +1012.09% |
| 2015-12-31 | Skr15.58 Million | -14.78% |
| 2014-12-31 | Skr18.28 Million | -- |